(0.18%) 5 140.50 points
(0.12%) 38 486 points
(0.25%) 17 891 points
(-0.01%) $83.84
(0.73%) $1.937
(0.27%) $2 353.50
(0.57%) $27.69
(2.19%) $942.25
(-0.18%) $0.933
(-0.35%) $10.99
(-0.30%) $0.798
(1.26%) $93.03
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 5.96%
@ $114.42
发出时间: 25 Apr 2024 @ 21:30
回报率: -2.19%
上一信号: Apr 24 - 00:19
上一信号:
回报率: -0.85 %
Live Chart Being Loaded With Signals
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States...
Stats | |
---|---|
今日成交量 | 427 515 |
平均成交量 | 452 493 |
市值 | 3.47B |
EPS | $0 ( 2024-02-22 ) |
下一个收益日期 | ( $-0.990 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -27.70 |
ATR14 | $3.25 (2.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-28 | Murphy Patrick Michael | Buy | 0 | |
2024-02-27 | Murphy Patrick Michael | Buy | 0 | |
2024-03-04 | Day Mark J. | Sell | 3 248 | Common Stock |
2024-03-04 | Patterson Chad | Sell | 1 077 | Common Stock |
2024-03-04 | Blackford Quentin S. | Sell | 4 221 | Common Stock |
INSIDER POWER |
---|
52.34 |
Last 96 transactions |
Buy: 380 179 | Sell: 104 612 |
音量 相关性
iRhythm Technologies Inc 相关性 - 货币/商品
iRhythm Technologies Inc 财务报表
Annual | 2023 |
营收: | $492.68M |
毛利润: | $331.81M (67.35 %) |
EPS: | $-4.04 |
FY | 2023 |
营收: | $492.68M |
毛利润: | $331.81M (67.35 %) |
EPS: | $-4.04 |
FY | 2022 |
营收: | $410.92M |
毛利润: | $281.63M (68.54 %) |
EPS: | $-3.88 |
FY | 2021 |
营收: | $322.83M |
毛利润: | $213.57M (66.16 %) |
EPS: | $-3.45 |
Financial Reports:
No articles found.
iRhythm Technologies Inc
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。